Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study

201484 citationsJournal Articlegold Open Access

Authors

The TRYPHAENA study was registered with ClinicalTrials.gov, NCT00976989, on September 14 2009.

Good health and well-being

Published in: Breast Cancer Research

Volume 16, Issue 4, pp. R73-R73

Field-Weighted Citation Impact: 5.52